Arkolith/Insider Trading/RSLS/Form 4

Stankovich Thomas

Chief Financial OfficerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Dec 20, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$63K
Net Open-Market Flow
-$63K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2022Sell(S)2K$0.15$332325K
Dec 1, 2022Sell(S)5K$0.15$772328K
Nov 28, 2022Sell(S)365K$0.17$62K333K
Nov 17, 2022Grant(A)365K—$0698K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-22-000136) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML